MT Van Lint
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Transplantation top 5%
Papers in
- Hematology 26
- Hematopoietic Stem Cell Transplantation 16
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 6
- Genetics 6
- Chronic Lymphocytic Leukemia Research 6
MT Van Lint
29 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 65
- Hematology 718
- Transplantation 48
- Immunology 331
- Genetics 142
- Public Health, Environmental and Occupational Health 327
Countries citing papers authored by MT Van Lint
This map shows the geographic impact of MT Van Lint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MT Van Lint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MT Van Lint more than expected).
Fields of papers citing papers by MT Van Lint
This network shows the impact of papers produced by MT Van Lint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MT Van Lint. The network helps show where MT Van Lint may publish in the future.
Co-authorship network
The 25 scholars most cited alongside MT Van Lint, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 18 | |
| 2 | 2001 | 233 | |
| 3 | Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft. | 2001 | 12 |
| 4 | 1999 | 39 | |
| 5 | 1999 | 34 | |
| 6 | 1999 | 1 | |
| 7 | 1998 | 52 | |
| 8 | 1998 | 23 | |
| 9 | 1997 | 69 | |
| 10 | 1997 | 43 | |
| 11 | 1997 | 115 | |
| 12 | 1997 | 33 | |
| 13 | 1996 | 3 | |
| 14 | 1992 | 18 | |
| 15 | 1987 | 0 | |
| 16 | 1987 | 45 | |
| 17 | 1985 | 1 | |
| 18 | 1982 | 2 | |
| 19 | 1982 | 4 | |
| 20 | 1981 | 2 |
About MT Van Lint
MT Van Lint is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Immunology and Oncology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), T-cell and B-cell Immunology (4 papers), Neutropenia and Cancer Infections (3 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Hematology (718 citations), Transplantation (48 citations), Immunology (331 citations), Genetics (142 citations) and Public Health, Environmental and Occupational Health (327 citations). MT Van Lint has collaborated with scholars based in Italy, France and Austria. Frequent co-authors include Andrea Bacigalupo, A Marmont, Francesca Gualandi, Teresa Lamparelli, D Occhini, Francesco Frassoni, Elisabetta Tedone, HJ Kolb, R Powles and M Hinterberger-Fischer. Their work appears in journals such as Blood, Bone Marrow Transplantation, American Journal of Hematology, The Lancet and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.